SCHEMBL29097943

SCHEMBL29097943

O=C(O)N1CCc2ccc(COc3ccc(Cl)cc3F)cc2C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MRGPRX4 Q96LA9 6/20 0.52
▸ HPGD P15428 3/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ S1PR1 P21453 2/20 0.43
▸ S1PR5 Q9H228 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ CHRM4 P08173 1/20 0.43
▸ MAPT P10636 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ PPARG P37231 2/20 0.41
▸ PPARA Q07869 2/20 0.41
▸ PTGDR2 Q9Y5Y4 1/20 0.41
▸ ESR1 P03372 1/20 0.40
▸ ESR2 Q92731 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ PREP P48147 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30199299 0.86 ESR2 (0.53) MRGPRX4HPGDSMN1; SMN2USP2CHRM4
SCHEMBL29097820 0.86 ESR2 (0.53) MRGPRX4HPGDSMN1; SMN2USP2CHRM4
SCHEMBL30474301 0.81 ERCC1 (0.45) HPGDSMN1; SMN2PTGDR2ESR1ESR2
SCHEMBL29098093 0.81 HRH3 (0.47) S1PR1S1PR5PREP
SCHEMBL29098088 0.79 HRH3 (0.53) S1PR1S1PR5ALDH1A1
SCHEMBL29390456 0.77 ESR1 (0.50) HPGDSMN1; SMN2ESR1ESR2KMT2A
SCHEMBL13623452 0.77 ESR1 (0.50) HPGDSMN1; SMN2ESR1ESR2KMT2A
SCHEMBL29098068 0.75 MAOB (0.51) MRGPRX4S1PR1S1PR5KMT2A
SCHEMBL29097811 0.74 HRH3 (0.44) S1PR1ESR1ESR2L3MBTL1
SCHEMBL22981196 0.74 ESR1 (0.43) HPGDSMN1; SMN2MAPTESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115594669-A Fused ring derivative and preparation method and medical application thereof 深圳信立泰药业股份有限公司(CN) 2023-01-13 — — CN disclosed
Send feedback